Shares of Cubist Pharmaceuticals CBST are lower on the session by 7.92%, trading at $29.08.
Overall put volume is now running at 8.07x the daily average, with 85% of all puts traded being purchases on the offer. 2,799 contracts have traded on the session so far.
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in